Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07141342 · ClinicalTrials.gov registry record · NA
Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Participate in a Weight Loss Program, Half Will Receive Bed Scales, and Participants Who Receive the Bed Scales Are Expected to Have Increased Weight Loss.
A NA study of Obesity & Overweight and Disability Physical, sponsored by Jonathan Pearlman.
- Recruiting
- Registry status
- NA
- Development phase
- 92
- Enrollment target
- 1
- Study location
NCT07141342: Recruiting NA study of Obesity & Overweight and Disability Physical, sponsored by Jonathan Pearlman.
NCT07141342 is a NA study of Obesity & Overweight and Disability Physical that is actively recruiting participants, run by Jonathan Pearlman. The registered enrollment target is 92 participants, below the 112-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07141342, a NA study of Obesity & Overweight and Disability Physical, is actively recruiting participants, sponsored by Jonathan Pearlman.
- RECRUITING
- Registry status
- NA
- Development phase
- 92 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will complete the final design and development steps to commercialize the Fast In-Bed Tracking (FIT) Platform, which is an e-Health and wellness Internet of Things (IoT) monitoring system that can be integrated into a user's bed and provide person-centered, real-world outcomes to support health and wellness. The technical feasibility of FIT was proven over the past several years and has demonstrated the platform can support the treatment of several chronic conditions across different populations, including obesity, congestive heart failure, and pressure injuries. The project goals will be to (1) complete design refinements for FIT and (2) demonstrate the platform's efficacy to support weight loss goals of wheelchair users. Wheelchair users are twice as likely as the general population to be overweight or obese and excess weight not only exacerbates mobility and participation limitations but increases risk for secondary health problems. Evidence reveals that frequent weight monitoring is a key driver for weight management, which puts wheelchair users at a significant disadvantage, because they have no convenient way to measure their body weight. As a recent example, lack of participant's ability to self-weigh was a noted limitation to a weight loss program for wheelchair users, known as the Group Lifestyle Balance weight loss program Adapted for Individuals with Impaired Mobility (GLB-AIM). FIT solves this challenge by passively monitoring a user's weight when they get on and off their bed. The investigators lab and community-based feasibility trials demonstrated that FIT successfully tracks weight for individuals and couples sharing a bed and that users find FIT highly usable. This proposed project will allow the investigators to complete the design refinements participants recommended during our community-based feasibility trial and subsequently examine the efficacy of FIT in supporting the weight-loss goals of community-dwelling wheelchair users throu
Primary Outcome
The difference in weight loss from baseline to 6 and 12 months (intervention versus control groups).
Conditions Studied
Interventions
- DEVICE The Fast In-Bed Tracking System (FIT) Weight Scale
- BEHAVIORAL Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) intervention
Study Locations (1)
Pennsylvania
- University of Pittsburgh, Bakery Square, Department of Rehabilitation Science and Technology - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 92 participants |
| Start Date | 2026-02-16 |
| Est. Completion | 2027-09 |
| Phase | NA |
What NCT07141342 shows while recruiting
NCT07141342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 112-participant average among 28 other Obesity & Overweight trials with a reported enrollment target (18% lower).
The record links to 3 conditions, with Obesity & Overweight appearing as the primary indexed condition, and to 2 interventions - of which The Fast In-Bed Tracking System (FIT) Weight Scale is the first listed.
NCT07141342 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07141342 about?
NCT07141342 is a clinical study titled "Fast In-Bed Tracking (FIT) System Lifestyle Intervention is a Clinical Trial of a Bed Scale Device. Overweight Wheelchair Users Will Participate in a Weight Loss Program, Half Will Receive Bed Scales, and Participants Who Receive the Bed Scales Are Expected to Have Increased Weight Loss.". This project will complete the final design and development steps to commercialize the Fast In-Bed Tracking (FIT) Platform, which is an e-Health and wellness Internet of Things (IoT) monitoring system that can be integrated into a user's bed and provide person-centered, real-world outcomes to suppor...
What is the current status of trial NCT07141342?
This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2026-02-16. Estimated completion is 2027-09.
What conditions does trial NCT07141342 study?
This clinical trial studies the following conditions: Obesity & Overweight, Disability Physical, Wheelchair.
What interventions are being tested in trial NCT07141342?
The interventions under investigation include: The Fast In-Bed Tracking System (FIT) Weight Scale (DEVICE), Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT07141342?
This trial is sponsored by Jonathan Pearlman, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07141342 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity & Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07141342's enrollment target sits among peer trials
92 12th of 28 higher than 17 of 28 other Obesity & Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity & Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
RECRUITING · NA
-
Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
RECRUITING · NA
-
Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
RECRUITING · NA
-
Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
RECRUITING · NA
-
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
RECRUITING · NA
-
Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03184545 · 92 participants · Phase 3
Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome
- NCT04172532 · 92 participants · Phase 1
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
- NCT04508088 · 92 participants
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease
- NCT04840602 · 92 participants · Phase 2
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI